Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints (Q5348691): Difference between revisions

@@ Property / MaRDI profile type @@
+MaRDI publication profile
@@ Property / MaRDI profile type: MaRDI publication profile / rank @@
+Normal rank
@@ Property / full work available at URL @@
+https://doi.org/10.1002/bimj.201600047
+Normal rank
@@ Property / OpenAlex ID @@
+W2593923038
@@ Property / OpenAlex ID: W2593923038 / rank @@
+Normal rank
@@ Property / Wikidata QID @@
+Q38927246
@@ Property / Wikidata QID: Q38927246 / rank @@
+Normal rank
@@ Property / cites work @@
+The frailty model.
@@ Property / cites work: The frailty model. / rank @@
+Normal rank
@@ Property / cites work @@
+Q4741623
@@ Property / cites work: Q4741623 / rank @@
+Normal rank
@@ Property / cites work @@
+Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification
+Normal rank
@@ Property / cites work @@
+Sample-Size Formula for the Proportional-Hazards Regression Model
+Normal rank
@@ Property / cites work @@
+The asymptotic theory of permutation statistics.
@@ Property / cites work: The asymptotic theory of permutation statistics. / rank @@
+Normal rank